Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cigna Corp (NY: CI ) 319.77 +0.28 (+0.09%) Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Cigna Corp < Previous 1 2 3 4 5 6 7 8 9 ... 20 21 Next > Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare November 09, 2024 Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. Via Benzinga Topics Government Exposures Political 3 Healthcare Stocks For Long-Term Growth And Dividends November 07, 2024 Healthcare stocks will profit from the U.S. aging population and pay rising dividends over time. Via Talk Markets Price Over Earnings Overview: Cigna November 04, 2024 Via Benzinga MarketBeat Week in Review – 10/28 - 11/1 November 02, 2024 Stocks staged a strong rally on Friday following a steep sell-off; a weak jobs report all but guarantees a rate cut which adds to bullish sentiment Via MarketBeat Topics Artificial Intelligence Economy Exposures Artificial Intelligence Interest Rates NYSE:CI is an undervalued gem with solid fundamentals. October 28, 2024 THE CIGNA GROUP (NYSE:CI): good value for what you're paying. Via Chartmill Investors seeking growth at a reasonable cost should explore NYSE:CI. October 28, 2024 THE CIGNA GROUP (NYSE:CI) is showing good growth, while it is not too expensive. Via Chartmill 11 Analysts Assess Cigna: What You Need To Know October 23, 2024 Via Benzinga Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday? October 31, 2024 Risk aversion swept across markets on Thursday as investor disappointment over third-quarter tech earnings triggered the steepest drop in major U.S. indices in nearly two months. Via Benzinga Cigna Group (CI) Q3 2024 Earnings Call Transcript October 31, 2024 CI earnings call for the period ending September 30, 2024. Via The Motley Fool Topics Earnings Exposures Financial Cigna's Q3 Profit Beats Street On Strong Demand For Pharmacy Benefit Management's Specialty Drugs, New Clients October 31, 2024 Cigna reports Q3 sales of $63.7 billion, a 30% YoY increase, driven by Evernorth growth. Adjusted EPS of $7.51 beats estimates. 2024 EPS guidance reaffirmed. Via Benzinga Here's How Much You Would Have Made Owning Cigna Stock In The Last 15 Years October 23, 2024 Via Benzinga $100 Invested In This Stock 15 Years Ago Would Be Worth $1,200 Today October 08, 2024 Via Benzinga A Glimpse Into The Expert Outlook On Cigna Through 11 Analysts October 01, 2024 Via Benzinga The Cigna Group Reports $63.7 Billion In Q3 Total Revenues, Better Than Expected October 31, 2024 The Cigna Group has reported impressive financial results for the third quarter of 2024. Via Talk Markets Cigna Considers Humana Acquisition – What It Means for the Stocks October 29, 2024 Rumors swirl around a potential Cigna (CI) and Humana (HUM) merger, but Medicare Advantage costs pose a significant challenge, making the merger risky. Via MarketBeat Jim Cramer: Buy Broadcom, But Stay Away From These Stocks October 25, 2024 The "Mad Money" host recommends buying Broadcom, but staying away from this bus manufacturer. "I just don't see the growth." Via Benzinga Why Cigna Group Stock Got Mashed on Monday October 21, 2024 A media report stated that the company is determined to grow with a major merger deal. Via The Motley Fool Stocks Fall As Treasury Yields, Dollar Rise; Nvidia Hits Record Highs: What's Driving Markets Monday? October 21, 2024 U.S. major indices fell on Monday as rising Treasury yields and a strengthening dollar dampened risk sentiment. Investors are reassessing the economic outlook and weighing potential risks tied to the... Via Benzinga NYSE:CI: good value for what you're paying. September 30, 2024 THE CIGNA GROUP (NYSE:CI) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. Via Chartmill NYSE:CI is showing good growth, while it is not too expensive. September 30, 2024 For those who appreciate growth without the sticker shock, THE CIGNA GROUP (NYSE:CI) is worth considering. Via Chartmill Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms October 21, 2024 Cigna and Humana are in early-stage merger discussions after a year-long pause. Amid financial pressure, Humana's Medicare Advantage star ratings have plummeted, impacting future revenue. Via Benzinga Cigna-Humana Merger Talks Back On With Tables Turned; 2024 Election Is Key October 21, 2024 Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled. Via Investor's Business Daily Market Briefing For Monday, Oct 21 October 21, 2024 Investors need to recognize that this time of year not only are more 'shakeouts' than we've seen likely; but tax-selling and shuffling (rearranging the Titanic deckchairs to some degree) is to be... Via Talk Markets SAP, Nucor And 3 Stocks To Watch Heading Into Monday October 21, 2024 Via Benzinga Pharmacy Retailer CVS Health Backs Away From Annual Forecast, Names New CEO October 18, 2024 CVS Health replaces CEO Karen Lynch with David Joyner as the company struggles with lower earnings projections and rising medical costs. Q3 2024 results, including a $1.1 billion charge, are expected... Via Benzinga CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit October 09, 2024 The FTC has filed a formal complaint accusing CVS, Cigna, and UnitedHealth of engaging in anti-competitive practices that inflate insulin prices. The complaint claims the PBMs' focus on rebates raises... Via Benzinga Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000% October 03, 2024 Texas Attorney General Ken Paxton sues major insulin manufacturers and PBMs, accusing them of conspiring to inflate insulin prices by as much as 1,000%, violating Texas law and harming diabetes... Via Benzinga Topics Lawsuit Exposures Financial Legal CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report October 01, 2024 CVS Health explores splitting its retail and insurance units to address investor concerns and financial challenges. The potential breakup could unwind the $70 billion Aetna acquisition made in 2017. Via Benzinga CVS Health in Focus as Activist Investor Prepares for High-Level Talks September 30, 2024 CVS Health is under pressure from hedge fund Glenview Capital as the company grapples with stock price drops, financial struggles with Medicare, and legal scrutiny of its pharmacy-benefit unit. Via Benzinga Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown? September 24, 2024 The FTC is going after these PBMs. Is this an opportunity for investors? Via The Motley Fool < Previous 1 2 3 4 5 6 7 8 9 ... 20 21 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
